Jiang Hao
Peking University People's Hospital · Hematology Institute · Beijing
1991,., 、 、 、.2003..2004.2013.2014.,;. 2001,,...,. CML., 1, 2, 3, 2.: 1. Hao Jiang, Shan-Shan Chen, Bin Jiang, Qian Jiang,Ya-Zhen Qin,Yue-Yun Lai,Xiao-Jun Huang Seven-year response to imatinib as initial treatment versus re-treatment in Chinese patients with chronic myelogenous leukemia in the chronic phase. Annals of Hematology, Ann Hematol. 2011 Jan;90(1):41-46. 2. Hao Jiang, Lanping Xu, Daihong Liu, Kaiyan Liu, Shanshan Chen, Bin Jiang, Qian Jiang, Huan Chen, Yuhong Chen, Wei Han, Xiaohui Zhang, Yu Wang, Jingzhi Wang, Fengrong Wang, Yazhen Qin, Yueyun Lai, Xiaojun Huang. Allogeneic hematopoietic stem cell transplantation in combination with tyrosine kinase inhibitor treatment compared to TKI treatment alone in chronic myelogenous leukemia blast crisis. Bone Marrow Transplantation, 2014 2.,,,,,,,. ABL.,2012;33(2):123-126 3、,,,,,,..,2012;32(2):135-137,, 1. 4、,,,,,,,,,,, *.55.,2013;45(6):938-944 5、, *,,,,.,,1999;10(31):395-398, 7. 6、, *,,,.,,2005;44(03):198-201. 、 、 、 、. 54 Ph.,2003;24(6):281-285 2001,,...,. CML., 1, 2, 3, 2. 2006 2011 2012 2016 | | | |:: 11:100044 ICP: ICP 10005257 -1 COPYRIGHT © 2004-2026:88326666: APP